Business Wire

Zendesk Adheres to Highest Standards of Data Protection With European BCR Approval

6.6.2017 11:00 | Business Wire

Jaa

Zendesk, Inc. (NYSE: ZEN) a leading provider of software for better customer relationships, today announced that it has completed the EU approval process with the Irish DPC (peer reviewed by both the UK Information Commissioner’s Office (ICO) and the Dutch Data Protection Authority (DPA)) for its global Binding Corporate Rules (BCRs) as data processor and controller. This significant regulatory approval validates Zendesk’s implementation of the highest possible standards for protecting personal data globally, covering both the personal data of its customers and its employees.

“We firmly believe in delivering certainty to our customers for the protection of their data. The approval of our BCRs is significant for us and demonstrates our ongoing commitment to protecting the privacy of personal data at Zendesk,” said John Geschke, general counsel and senior vice president of administration at Zendesk. “In addition to our BCRs, Zendesk is a certified signatory to EU-US Privacy Shield and at the request of its customers will enter into the Zendesk Data Processing Agreement, which includes EU model clauses.”

“This provides further confirmation that Zendesk is a global business that values security and data privacy at its core,” said John Crossan, vice president EMEA at Zendesk. “As a result of the Irish DPC’s approval of our BCRs, companies across Europe know when they deal with Zendesk, they are dealing with one of the most secure customer relationship software providers globally with the highest data protection standards available today.”

BCRs are internal company-specific data protection policies enabling a global business the ability to transfer personal data within the company (as a data controller) and to process personal data of its EEA customers on an intra-group basis anywhere in the world (as a data processor).

Approval is based on rigorous criteria set out by the European Data Protection Agencies and the process required a thorough review of Zendesk’s global data privacy compliance policies and procedures as required by the EU DPAs. Zendesk is one of only a few software companies in the world to have received approval for its BCRs; and just the second company ever to receive approval from the Irish DPC. It was supported throughout the BCR regulatory approval process by leading European law firm, Fieldfisher.

BCRs make it possible for multinational companies to standardise their practices relating to the protection of personal data by assuring an identical level of protection and security, benchmarked against rigorous European data protection standards, regardless of where the customer is based in the world. They demonstrate that data protection is integral to the way a company carries out its business and are validation that the company has the highest possible standard for dealing with data. This provides assurance for even the most privacy and security conscious companies around the world when working with Zendesk.

A Forrester report into EU data protection laws highlighted that implementing BCRs demonstrates additional data protection dedication and can ease data transfer concerns for EU decision-makers. A growing number of multinational companies believe that BCRs are an appropriate and practical mechanism for managing transborder flows of personal data.

Zendesk has more than 101,000 paid customer accounts globally across a range of industries. In the EMEA region, the company has over 35,000 paid customer accounts in EMEA growing at over 30 percent year over year to end March 2017 including John Lewis, Trustpilot, Lampiris and e-Boks.

In addition to the approval of its BCRs, Zendesk has achieved its SOC 2 Type II compliance. Zendesk also complies with ISO 27001:2013 and 27018:2014, the standard for protecting Personally Identifiable Information (PII) in the cloud, set forth by the International Standards Organisation. Also, Zendesk, Inc. has been approved to sell its cloud software services on the UK Government Digital Marketplace's 'G-Cloud 9' framework.

About Zendesk

Zendesk builds software for better customer relationships. It empowers organizations to improve customer engagement and better understand their customers. More than 101,000 paid customer accounts in over 160 countries and territories use Zendesk products. Based in San Francisco, Zendesk has operations in the United States, Europe, Asia, Australia, and South America. Learn more at www.zendesk.com.

Source: Zendesk, Inc.

Contact information

Zendesk, Inc.
Andy Sommer, +44 7724419227
asommer@zendesk.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

IFF to Present at the Barclays Global Consumer Staples Conference21.8.2017 23:15Tiedote

Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF), a leading innovator of sensory experiences that move the world, today announced that Andreas Fibig, Chairman and Chief Executive Officer will present at the Barclays Global Consumer Staples Conference in Boston, MA on Thursday, September 7, 2017 at 11:15 a.m. EDT. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Meet IFF International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for explorati

Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform21.8.2017 23:11Tiedote

Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative disease. Celularity completed their Series A financing with contributions from several biopharma companies, including Sorrento Therapeutics, United Therapeutics Corporation and Human Longevity, Inc., and entrepreneurial investors. Celularity has been created through the contributions of extensive intellectual property, clinical-stage assets, basic and clinical research, and development expertise including: Several clinical-stage immuno-oncology and regenerative medicine assets and a pipeline of pre-clinical assets Proprietary allogeneic (“readily accessible”) immunotherapy platform 200+ issued and pending patents in cell therapy

European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 16:25Tiedote

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the

IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 15:00Tiedote

IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman

PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 11:03Tiedote

PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate

Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 11:00Tiedote

Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme